FIELD: pharmaceutics.
SUBSTANCE: invention relates to production of pharmaceutical dosage form containing rosuvastatin calcium salt. Pharmaceutical dosage form contains tablet core, coated by spraying of sublayer forming polymer. Sublayer is covered with layer of active agent by means of spraying solution, which contains rosuvastatin calcium salt, calcium acetate and polymer hydroxypropylmethylcellulose/polyethylene glycol in water. Layer of active agent is additionally coated with external layer, containing polymer hydroxypropyl methylcellulose and iron oxide.
EFFECT: pharmaceutical dosage form under invention is stable for long period of time.
16 cl, 1 dwg, 18 tbl, 18 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS CONTAINING AMINO COMPOUND | 2012 |
|
RU2607480C2 |
PHARMACEUTICAL COMPOSITION CONTAINING OLMESARTAN MEDOXOMIL AND ROSUVASTATIN OR ITS SALT | 2013 |
|
RU2616516C2 |
COMBINED COMPOSITION CONTAINING METFORMIN OF SUSTAINED RELEASE AND INHIBITOR HMG-CoA-REDUCTASE OF IMMEDIATE RELEASE | 2014 |
|
RU2651460C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING DIACEREIN | 2009 |
|
RU2542461C2 |
PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2589842C2 |
NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
ORAL PHARMACEUTICAL MEDICINAL FORM WITH DISCRETE RELEASE | 1998 |
|
RU2205028C2 |
COMPOSITIONS OF PILL WITH IMMEDIATE RELEASE | 2010 |
|
RU2558798C2 |
COATED TABLET AND METHOD FOR PREPARING THEREOF | 2005 |
|
RU2372894C2 |
PHARMACEUTICAL COMPOSITION CONTAINING ROSUVASTATIN CALCIUM SALT (VERSIONS) | 2015 |
|
RU2606592C1 |
Authors
Dates
2016-11-20—Published
2012-05-17—Filed